The public issue is entirely an offer-for-sale (OFS) of up to 21.7 million shares by the promoters and other shareholders to the tune of around ₹1,800 crore, said bankers. The company operates under the “Blue Jet” brand offering niche products targeted at innovator pharmaceutical companies and multinational generic pharmaceutical companies.
Top 10 PSU performers in CY24. Here’s how much they have returned
As we are at the fag end of 2024, a look back at the performance of PSU stocks shows BSE PSU index delivering nearly 29%
December 21, 2024